Table 1.
The association between smoking status and patients' overall survival.
| Cancer type | Current smoker | Reformed smoker | Age‐adjusted HR (95% CI) | P‐value | MV‐adjusted HR (95% CI) a | P‐value |
|---|---|---|---|---|---|---|
| BLCA | 91 | 198 | 0.79 (0.54–1.16) | 0.230 | 0.72 (0.42–1.22) | 0.219 |
| CESC b | 64 | 53 | 0.34 (0.16–0.71) | 0.004 | 0.63 (0.26–1.53) | 0.309 |
| ESCA | 37 | 73 | 0.89 (0.46–1.72) | 0.723 | 0.89 (0.39–2.02) | 0.780 |
| HNSC b | 178 | 215 | 0.65 (0.47–0.89) | 0.007 | 0.67 (0.44–1.02) | 0.059 |
| LUAD | 122 | 311 | 1.12 (0.77–1.63) | 0.561 | 1.34 (0.85–2.10) | 0.207 |
| LUSC | 134 | 340 | 0.62 (0.46–0.83) | 0.001 | 0.67 (0.48–0.94) | 0.020 |
| PAAD | 20 | 60 | 0.45 (0.23–0.89) | 0.021 | 0.54 (0.24–1.20) | 0.132 |
Significant associations are shown in bold.
a
MV‐adjusted for age (continuous), gender (female, male), tumor stage (stage Ⅰ, stage Ⅱ, stage Ⅲ, and stage Ⅳ), and tumor status (with tumor and tumor‐free).
b
MV‐adjusted for age (continuous), gender (female, male), tumor stage (stage Ⅰ, stage Ⅱ, stage Ⅲ, and stage Ⅳ), tumor status (with tumor and tumor‐free), and HPV status (positive and negative).